Fudan University Shanghai Cancer Center
Shanghai, China
Location status: Recruiting
NCT Number: NCT07371273
This comparative study evaluates the short- and long-term outcomes of Quadrant-based Intersphincteric Resection (Q-ISR) versus traditional subtotal ISR (Sub-ISR) and conventional/total ISR (t-ISR) in patients with ultra-low rectal cancer undergoing sphincter-preserving surgery, with short-term endpoints focusing on perioperative safety (operative time, blood loss, length of stay, and postoperative complications such as Clavien-Dindo grade ≥II, anastomotic leakage/stricture, and stoma reversal) and long-term endpoints assessing anorectal function recovery (LARS and Wexner scores after stoma closure) and oncologic efficacy (R0 resection, recurrence patterns, and survival outcomes), aiming to determine whether a quadrant-tailored resection strategy can better balance tumor control with anal function preservation.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Phase 2
Shanghai, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Q-ISR (Quadrant-based ISR): Based on preoperative precise assessment and rectal endoscopic localization, selective resection of the internal sphincter is performed "by quadrant and quantificationally" according to the extent of lesion involvement, while striving to preserve the uninvolved quadrants and the external sphincter-levator ani complex. This aims to ensure R0 resection margins and oncological safety, while reducing the risk of low anterior resection syndrome (LARS) and accelerating the recovery of bowel control function.
Time frame: 3years
Time frame: 3years
Time frame: 5years
Interested in participating?
Request InfoFudan University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07670312
Adnexal Diseases, Bronchial Neoplasms
Sydney, New South Wales, Australia
View Trial DetailsNCT07525206
Colonic Diseases, Colorectal Cancer
East Brunswick, New Jersey, United States
View Trial DetailsNCT06004245
Advanced Solid Tumors, Colonic Diseases
Duarte, California, United States
View Trial DetailsNCT06047379
Adenocarcinoma, Astrocytoma
Beverly Hills, California, United States
View Trial Details